Breast Neoplasms: all 12,820 studies

Page 38 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerCompletedNCT02278120Phase 3Results posted
• Prone Partial Breast Irradiation (PBI): a Prospective Randomized TrialActive, not recruitingNCT02276885Not applicableResults posted
• A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)CompletedNCT02273973Phase 2Results posted
• Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerTerminatedNCT02273752Phase 2Results posted
• Phase II Study of Everolimus Beyond ProgressionTerminatedNCT02269670Phase 2Results posted
• Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)Active, not recruitingNCT02263014Results posted
• Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain MetastasesCompletedNCT02260531Phase 2Results posted
• Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast CancerTerminatedNCT02258464Phase 2Results posted
• Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast CancerCompletedNCT02258451Phase 2Results posted
• A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast CancerActive, not recruitingNCT02246621Phase 3Results posted
• Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk ScoreTerminatedNCT02236572Phase 2Results posted
• A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast CancerCompletedNCT02236000Phase 1/2Results posted
• Vaccination of High Risk Breast Cancer Patients - A Combined Phase I/II Feasibility-and-Efficacy StudyCompletedNCT02229084Phase 1/2Results posted
• Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast CancerActive, not recruitingNCT02226276Not applicableResults posted
• Nueva Vida Intervention for Latina Breast Cancer Survivors and CaregiversCompletedNCT02222337Not applicableResults posted
• Tumor: Breast Ratio StudyCompletedNCT02216136Results posted
• Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast CancerTerminatedNCT02213042Phase 2Results posted
• Surveillance Imaging Modalities for Breast Cancer AssessmentCompletedNCT02212834Results posted
• Endocrine Response in Women With Invasive Lobular Breast CancerCompletedNCT02206984Phase 2Results posted
• Breast Health Education for Underserved Latino WomenCompletedNCT02205736Not applicableResults posted
• Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation TherapyCompletedNCT02203565Phase 2Results posted
• Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast CancerCompletedNCT02203552Phase 2Results posted
• A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate CancerTerminatedNCT02203513Phase 2Results posted
• A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast CancerTerminatedNCT02202746Phase 2Results posted
• Single Versus Double Drains After MastectomyCompletedNCT02202252Not applicableResults posted
• Cryoablation of Low Risk Small Breast Cancer- ICE3 TrialCompletedNCT02200705Not applicableResults posted
• ER Reactivation Therapy for Breast CancerCompletedNCT02188745Phase 2Results posted
• Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast CancerCompletedNCT02187991Phase 2Results posted
• A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)CompletedNCT02187744Phase 3Results posted
• Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)CompletedNCT02186015Phase 2Results posted
• Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk StratificationCompletedNCT02177175Phase 2Results posted
• Reproductive Health Survivorship Care Plan PilotCompletedNCT02176083Not applicableResults posted
• HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast CancerCompletedNCT02165605Not applicableResults posted
• A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast CancerCompletedNCT02163694Phase 3Results posted
• A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal ReceptorsCompletedNCT02162719Phase 2Results posted
• Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast CancerCompletedNCT02162667Phase 3Results posted
• Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast CancerTerminatedNCT02154529Phase 1/2Results posted
• Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"CompletedNCT02154139Results posted
• A Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast CancerCompletedNCT02149524Phase 3Results posted
• F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted TherapyTerminatedNCT02149173Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast CancerTerminatedNCT02144012Phase 3Results posted
• Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast CancerCompletedNCT02139358Phase 1/2Results posted
• S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast CancerTerminatedNCT02137837Phase 3Results posted
• Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast CancerTerminatedNCT02137252Phase 2Results posted
• Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"CompletedNCT02134977Results posted
• A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast CancerCompletedNCT02132949Phase 2Results posted
• A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerCompletedNCT02131064Phase 3Results posted
• Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast CancerCompletedNCT02129556Phase 1/2Results posted
• A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid TumorsTerminatedNCT02129205Phase 1Results posted
• Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast CancerTerminatedNCT02127073Phase 2Results posted
• A Pilot Trial to Assess the Impact of Acupuncture on Post-mastectomy Pain, Nausea, Anxiety and Ability to CopeCompletedNCT02122796Not applicableResults posted
• Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast CancerCompletedNCT02120469Phase 1Results posted
• A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast CancerTerminatedNCT02120417Phase 2Results posted
• Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast CancerCompletedNCT02115984Phase 2Results posted
• Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant ChemotherapyCompletedNCT02115607Not applicableResults posted
• Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticActive, not recruitingNCT02115282Phase 3Results posted
• Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole AloneTerminatedNCT02115048Phase 2Results posted
• A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast CancerActive, not recruitingNCT02107703Phase 3Results posted
• Accelerated Partial Breast Irradiation Using Intensity Modulated Radiotherapy Versus Whole Breast IrradiationCompletedNCT02104895Phase 3Results posted
• A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has SpreadCompletedNCT02102490Phase 2Results posted
• Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast CancerCompletedNCT02101385Phase 2Results posted
• Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent SimvastatinTerminatedNCT02096588Phase 2Results posted
• GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese PatientsTerminatedNCT02095184Not applicableResults posted
• A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast CancerCompletedNCT02091960Phase 2Results posted
• Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant ReconstructionsCompletedNCT02086578Phase 2Results posted
• Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast CancerCompletedNCT02076074Not applicableResults posted
• Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With PaclitaxelCompletedNCT02073487Phase 2Results posted
• Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast CancerCompletedNCT02069093Phase 2Results posted
• Olive Oil for High Risk Breast Cancer Prevention in WomenCompletedNCT02068092Phase 2/3Results posted
• Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast CancerCompletedNCT02066532Phase 1/2Results posted
• HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast CancerCompletedNCT02063724Phase 1Results posted
• Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line TreatmentCompletedNCT02061085Phase 2Results posted
• A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast CancerTerminatedNCT02054338Phase 3Results posted
• Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast CancerCompletedNCT02049957Phase 2Results posted
• Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory BrcaCompletedNCT02041429Phase 1/2Results posted
• Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast CancerCompletedNCT02040857Phase 2Results posted
• BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane TxCompletedNCT02038010Phase 1Results posted
• Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast CancerSuspendedNCT02037529Phase 3Results posted
• A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)TerminatedNCT02034916Phase 2Results posted
• Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerActive, not recruitingNCT02032823Phase 3Results posted
• Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase InhibitorsCompletedNCT02028507Phase 3Results posted
• Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer RiskCompletedNCT02028221Phase 2Results posted
• Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) PatientsCompletedNCT02027376Phase 1Results posted
• A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast CancerCompletedNCT02019277Phase 3Results posted
• Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast CancerCompletedNCT02018458Phase 1/2Results posted
• A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast CancerCompletedNCT02015676Phase 1/2Results posted
• Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.CompletedNCT02010021Not applicableResults posted
• A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid TumorsCompletedNCT02009449Phase 1Results posted
• Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast CancerCompletedNCT02007512Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast CancerCompletedNCT02005549Phase 2Results posted
• Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast CancerCompletedNCT02003209Phase 3Results posted
• Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyCompletedNCT02002533Not applicableResults posted
• Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)CompletedNCT02001974Phase 1Results posted
• STAR Cape+BKM120 MBC With Brain MetCompletedNCT02000882Phase 2Results posted
• Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.CompletedNCT02000622Phase 3Results posted
• 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.TerminatedNCT02000596Phase 2Results posted
• A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast CancerCompletedNCT01998906Phase 3Results posted
• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast CancerCompletedNCT01997333Phase 2Results posted
• The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer PatientsTerminatedNCT01996410Not applicableResults posted
• Correlate BRCA1 Protein Expression With Response to DNA Damaging ChemotherapyTerminatedNCT01990352Phase 2Results posted

← Breast Neoplasms overview